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Experimental Section
General Procedure for Barbier-type reaction: In a dry round bottom flask equipped with a reflux condenser was taken indium metal powder (4.06 mmol, 2 eq) and ammonium chloride (4.06 mmol, 2 eq). To it was added a solution of methyl 2-(bromomethyl) acrylate (2.45 mmol, 1.2 eq) in dry THF (5 mL). The reaction mixture was heated at 50 C for 15 minutes followed by addition of a solution of isatin/isatin derivatives (2.03 mmol, 1 eq) in 5 mL THF. Reaction mixture was heated at 50 C with constant stirring for 30 minutes and reaction completion (disappearance of isatin) was monitored by thin layer chromatography using 50% ethyl acetate in hexane solvent. Following reaction completion, reaction mixture was cooled to room temperature and passed through silica gel to remove ammonium chloride and indium metal.
Reaction solvent was evaporated under reduced pressure using rotavapor. Crude reaction mixture was dissolved in 0.1% HCl and extracted using ethyl acetate followed by washing with brine, and dried using magnesium sulfate. Crude mixture was column chromatographed using hexane and ethyl acetate gradient to obtain spirocyclic compound and acyclic compound respectively. 
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General procedure for the reduction reaction for spiro compounds: Taken spiro compound (0.11 mmol) in round bottom flask and added 4 mL of dry THF via syringe. To the reaction mixture was added Pd/C (5 mg, 5 % by weight on activated carbon) and nitrogen gas was bubbled though the reaction mixture for about 10 minutes. Reaction mixture was gently vacuumed and was kept under hydrogen atmosphere for 5 hours (Note: Reaction was monitored by NMR spectroscopy as longer time leads to over reduction of carbonyl group of lactone). After completion of reaction, mixture was passed through a bed of celite and column chromatographed using hexane and ethyl acetate gradient to obtained product as white solid.
General procedure for the reduction reaction for acyclic compounds: Taken acyclic compound (0.36 mmol) in round bottom flask and added 8 mL of dry THF via syringe. To the reaction mixture was added Pd/C (20 mg, 5 % by weight on activated carbon) and nitrogen gas was bubbled though the reaction mixture for about 10 minutes. Reaction mixture was gently vacuumed and was kept under hydrogen atmosphere for 24 hours. After completion of reaction, mixture was passed through a bed of celite and column chromatographed using hexane and ethyl acetate gradient to obtained product as colorless oil.
General procedure for the cyclization reaction of acyclic compounds: Taken acyclic compound (0.25 mmol, 1 eq.) in round bottom flask and added 5 mL of dichloromethane via syringe followed by addition of p-toluenesulfonic acid monohydrate salt (0.25 mmol, 1 eq.).
Reaction mixture was stirred at room temperature for 12 h under nitrogen atmosphere.
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